Tocqueville Asset Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Tocqueville Asset Management’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-277,450	Closed	-$4.85M	–	749
2020 Q4	$4.85M	Buy	277,450 +10,000	+4%	+$140K	0.08%	237
2020 Q3	$3.13M	Buy	267,450 +207,450	+346%	+$2.75M	0.06%	262
2020 Q2	$780K	Buy	60,000 +48,500	+422%	+$583K	0.02%	415
2020 Q1	$106K	Hold	11,500	–	–	﹤0.01%	617
2019 Q4	$191K	Hold	11,500	–	–	﹤0.01%	707
2019 Q3	$191K	Buy	+11,500	New	+$159K	﹤0.01%	725

Tocqueville Asset Management's OXFD Position: Q1 2021 in Review

Tocqueville Asset Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 277,450 shares — an estimated $4.85M sold.

Tocqueville Asset Management first reported a position in OXFD in Q3 2019 and held it in 6 quarters. The position peaked at $4.85M in Q4 2020. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.

Tocqueville Asset Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
Tocqueville Asset Management sold 277,450 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $4.85M.
Tocqueville Asset Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q3 2019 and held it in 6 quarters.
Tocqueville Asset Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $4.85M in Q4 2020.
0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.

Based on Tocqueville Asset Management's 13F filing for Q1 2021, filed 17 May 2021.